Gabapentinoids

Key figures

PRESCRIBERS
Main prescribers: General practitioners	72.40%
INSURED CONSUMERS
% of insured consumers	1.80%
Median age	64 years
Max/min ratio of the median age (by district)	1.10
Percentage of women	60.48%
Ratio Preferential scheme/General scheme	2.40
Coefficient of variation (2023)	20.02
Max/min ratio of % of insured consumers (by district)	2.21
CONSUMPTION
Annual consumption (DDD)	28,901,060
Consumption of DDD (per 100,000 insured persons)	250,866.26
% DDD issued outside the insurance (approximate)	5.13%
Average annual consumption per insured consumer (DDD)	139.02
% of insured consumers with > 3 times the average consumption	7,04%
Coefficient of variation 2013-2015	20.09
Coefficient of variation 2021-2023	17.51
Trend 2013-2023	9.56%
Trend 2013-2021	11.50%
Trend 2021-2023	2.14%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	18,196,262 €
Average annual expenditure per insured person	1.58 €
Average patient share per insured consumer	18.86%
Max/min ratio of expenditure per insured person (by disctrict)	1.91
% “Low-cost” medication	100.00%
Trend 2013-2023	-2.09%
Trend 2021-2023	1.79%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.